We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
Cap. Flow
-$1.7B
Cap. Flow %
-1.7%
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 16.9%
2 Industrials 13.89%
3 Financials 12.91%
4 Consumer Discretionary 10.69%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMO
2626
DELISTED
Romeo Power, Inc.
RMO
$15K ﹤0.01%
13,695
-6,646
-33% -$14K
PAVM icon
2627
PAVmed
PAVM
$34M
$14K ﹤0.01%
25
-2
-7% -$1.49K
TCRT icon
2628
Alaunos Therapeutics
TCRT
$4.84M
$14K ﹤0.01%
175
-5
-3% -$642
VGZ icon
2629
Vista Gold
VGZ
$326M
$14K ﹤0.01%
15,912
-454
-3% -$373
ASXC
2630
DELISTED
Asensus Surgical, Inc.
ASXC
$14K ﹤0.01%
31,161
-889
-3% -$685
NMTR
2631
DELISTED
9 Meters Biopharma
NMTR
$14K ﹤0.01%
1,718
-86
-5% -$1.17K
DARE icon
2632
Dare Bioscience
DARE
$20.4M
$13K ﹤0.01%
965
+73
+8% +$1.38K
FTK icon
2633
Flotek Industries
FTK
$1.36B
$13K ﹤0.01%
1,692
-65
-4% -$464
SVRA icon
2634
Savara
SVRA
$1.17B
$13K ﹤0.01%
11,114
-316
-3% -$381
DS
2635
DELISTED
Drive Shack Inc.
DS
$13K ﹤0.01%
10,420
-297
-3% -$403
CFMS
2636
DELISTED
Conformis, Inc. Common Stock
CFMS
$13K ﹤0.01%
979
-17
-2% -$279
ADVM
2637
DELISTED
Adverum Biotechnologies
ADVM
$12K ﹤0.01%
1,138
-33
-3% -$483
DRRX
2638
DELISTED
DURECT Corp
DRRX
$12K ﹤0.01%
2,671
-76
-3% -$528
FBIO icon
2639
Fortress Biotech
FBIO
$91.4M
$12K ﹤0.01%
733
-21
-3% -$575
PTN
2640
Palatin Technologies
PTN
$13.1M
$12K ﹤0.01%
25
RNAC icon
2641
Cartesian Therapeutics
RNAC
$265M
$12K ﹤0.01%
534
+127
+31% +$7.94K
TXMD icon
2642
TherapeuticsMD
TXMD
$24M
$12K ﹤0.01%
1,142
-32
-3% -$503
XWEL icon
2643
XWELL
XWEL
$8.06M
$12K ﹤0.01%
659
-94
-12% -$2.52K
OIG
2644
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$12K ﹤0.01%
+260
New +$17.5K
EPZM
2645
DELISTED
Epizyme, Inc
EPZM
$12K ﹤0.01%
18,843
+8,263
+78% +$13.5K
AKBA icon
2646
Akebia Therapeutics
AKBA
$234M
$10K ﹤0.01%
23,013
-657
-3% -$1.41K
CARM
2647
DELISTED
Carisma Therapeutics
CARM
$10K ﹤0.01%
1,326
-52
-4% -$726
TNXP icon
2648
Tonix Pharmaceuticals
TNXP
$201M
0
WATT icon
2649
Energous
WATT
$102M
$10K ﹤0.01%
17
HOFV
2650
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$9K ﹤0.01%
+501
New +$12.9K

Similar funds

Victory Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
  • Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
  • Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
  • Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
  • Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
  • Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
  • Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.